Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50


14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression.

Mukhopadhyay A, Sehgal L, Bose A, Gulvady A, Senapati P, Thorat R, Basu S, Bhatt K, Hosing AS, Balyan R, Borde L, Kundu TK, Dalal SN.

Sci Rep. 2016 Jun 2;6:26580. doi: 10.1038/srep26580.


Downregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.

Wang Y, Zhou X, Shan B, Han J, Wang F, Fan X, Lv Y, Chang L, Liu W.

Mol Med Rep. 2015 Nov;12(5):6491-500. doi: 10.3892/mmr.2015.4296.


Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.

Gong Y, Zack TI, Morris LG, Lin K, Hukkelhoven E, Raheja R, Tan IL, Turcan S, Veeriah S, Meng S, Viale A, Schumacher SE, Palmedo P, Beroukhim R, Chan TA.

Nat Genet. 2014 Jun;46(6):588-94. doi: 10.1038/ng.2981.


Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.

Bittar C, Shrivastava S, Bhanja Chowdhury J, Rahal P, Ray RB.

PLoS One. 2013 Apr 30;8(4):e62581. doi: 10.1371/journal.pone.0062581.


Recent progress in studies of arterivirus- and coronavirus-host interactions.

Zhong Y, Tan YW, Liu DX.

Viruses. 2012 Jun;4(6):980-1010. doi: 10.3390/v4060980. Review.


Mir-33 regulates cell proliferation and cell cycle progression.

Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ramírez CM, Chamorro-Jorganes A, Wanschel AC, Lasuncion MA, Morales-Ruiz M, Suarez Y, Baldan Á, Esplugues E, Fernández-Hernando C.

Cell Cycle. 2012 Mar 1;11(5):922-33. doi: 10.4161/cc.11.5.19421.


MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells.

Bridges KA, Hirai H, Buser CA, Brooks C, Liu H, Buchholz TA, Molkentine JM, Mason KA, Meyn RE.

Clin Cancer Res. 2011 Sep 1;17(17):5638-48. doi: 10.1158/1078-0432.CCR-11-0650.


A Preclinical Evaluation of Antrodia camphorata Alcohol Extracts in the Treatment of Non-Small Cell Lung Cancer Using Non-Invasive Molecular Imaging.

Chiou JF, Wu AT, Wang WT, Kuo TH, Gelovani JG, Lin IH, Wu CH, Chiu WT, Deng WP.

Evid Based Complement Alternat Med. 2011;2011:914561. doi: 10.1093/ecam/nep228.


Ca(2+) signaling, genes and the cell cycle.

Machaca K.

Cell Calcium. 2010 Nov;48(5):243-50. doi: 10.1016/j.ceca.2010.10.003. Review.


Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.

Li G, Park HU, Liang D, Zhao RY.

Retrovirology. 2010 Jul 7;7:59. doi: 10.1186/1742-4690-7-59.


Examination of the expanding pathways for the regulation of p21 expression and activity.

Jung YS, Qian Y, Chen X.

Cell Signal. 2010 Jul;22(7):1003-12. doi: 10.1016/j.cellsig.2010.01.013. Review.


Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway.

Meng AG, Jiang LL.

Acta Pharmacol Sin. 2009 Apr;30(4):442-50. doi: 10.1038/aps.2009.20.


Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents.

Liu ZG, Zhao LN, Liu YW, Li TT, Fan DM, Chen JJ.

J Mol Biol. 2007 Nov 23;374(2):334-45.


Effects of ethanol on hepatic cellular replication and cell cycle progression.

Clemens DL.

World J Gastroenterol. 2007 Oct 7;13(37):4955-9. Review.


Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.

Hashimoto O, Shinkawa M, Torimura T, Nakamura T, Selvendiran K, Sakamoto M, Koga H, Ueno T, Sata M.

BMC Cancer. 2006 Dec 19;6:292.


Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins.

Gaspar M, Shenk T.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2821-6.


The Vpr protein from HIV-1: distinct roles along the viral life cycle.

Le Rouzic E, Benichou S.

Retrovirology. 2005 Feb 22;2:11. Review.


Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.

Uto K, Inoue D, Shimuta K, Nakajo N, Sagata N.

EMBO J. 2004 Aug 18;23(16):3386-96.

Items per page

Supplemental Content

Support Center